Parse Biosciences launched the Evercode WT Penta and Penta 384 platforms, enabling whole transcriptome single-cell RNA sequencing at unprecedented scales—up to five million cells and 384 samples per run. The technology uses split-pool combinatorial barcoding to uniquely label individual cells for high-throughput gene expression profiling, facilitating rare cell detection, drug screening, and large-scale oncology research.